Patents by Inventor Hanns-Joachim Rziha

Hanns-Joachim Rziha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT ORF VIRUS VECTOR
    Publication number: 20220204992
    Abstract: A nucleic acid molecule can code for an Orf virus vector promoter. A recombinant Orf virus vector can be included in a cell. The nucleic acid molecule, the vector and/or the cell can be included in a composition. The recombinant Orf virus vector can be used for the production of a foreign gene.
    Type: Application
    Filed: March 17, 2022
    Publication date: June 30, 2022
    Inventors: Hanns-Joachim Rziha, Ralf Amann
  • Recombinant Orf virus vector
    Patent number: 11286500
    Abstract: A nucleic acid molecule can code for an Orf virus vector promoter. A recombinant Orf virus vector can be included in a cell. The nucleic acid molecule, the vector and/or the cell can be included in a composition. The recombinant Orf virus vector can be used for the production of a foreign gene.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: March 29, 2022
    Assignee: EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT
    Inventors: Hanns-Joachim Rziha, Ralf Amann
  • PARAPOXVIRUS EXPRESSING THE VP60 MAJOR CAPSID PROTEIN OF THE RABBIT HAEMORRHAGIC DISEASE VIRUS
    Publication number: 20130177582
    Abstract: The invention describes a therapeutic agent capable of treating and/or preventing rabbit haemorrhagic disease virus infection in rabbits, namely a recombinant parapoxvirus, characterized in that the VP60 major capsid protein from the rabbit haemorrhagic disease virus (RHDV) is expressed from a foreign nucleic acid.
    Type: Application
    Filed: April 29, 2011
    Publication date: July 11, 2013
    Applicant: RIEMSER ARZNEIMITTEL AG
    Inventor: Hanns-Joachim Rziha